In a report released yesterday, Hartaj Singh from Oppenheimer maintained a Buy rating on Viracta Therapeutics (VIRX), with a price target of $36.00.
Jefferies analyst Brent Thill maintained a Buy rating on Amazon (AMZN) on June 15 and set a price target of $4200.00.
After Robert W. Baird and Jefferies gave Freshpet (NASDAQ: FRPT) a Buy rating last month, the company received another Buy, this time from …
In a report released today, Rupesh Parikh from Oppenheimer maintained a Hold rating on Sally Beauty (SBH). The company’s shares closed last Wednesday …
In a report released today, Rupesh Parikh from Oppenheimer assigned a Buy rating to UTZ Brands (UTZ), with a price target of $29.00.
After Wedbush and Piper Sandler gave Shake Shack (NYSE: SHAK) a Buy rating last month, the company received another Buy, this time from …
In a report released today, Elliot Wilbur from Raymond James maintained a Hold rating on Elanco Animal Health (ELAN). The company’s shares closed …
Raymond James analyst Danielle Brill maintained a Hold rating on Sarepta Therapeutics (SRPT) today. The company’s shares closed last Wednesday at $82.
There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on American Tower (AMT) and Signature …
In a report released today, Brian Bittner from Oppenheimer assigned a Buy rating to Papa John’s International (PZZA), with a price target of …
